Journal profile · Gastroenterology & Hepatology
Journal of Clinical Gastroenterology
ISSN 0192-0790 · eISSN 1539-2031 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1979
Journal of Clinical Gastroenterology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.32; JCR Q3 (journal website); hybrid open access; median 118 days to acceptance (22 articles, last 24 months); community-reported acceptance: fairly easy; 188 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Clinical Gastroenterology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Helicobacter pylori-related gastroenterology studies, Gastroesophageal reflux and treatments and Liver Disease Diagnosis and Treatment, together about 20.9% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
While glucagon-like peptide 1 receptor agonists (GLP1-RAs) increase the risk of gastric food retention (GFR) and inadequate bowel preparation (IBP), the confounding role of diabetes mellitus is still questioned. Here, we compare the outcomes of endoscopic procedures in patients on GLP1-RAs versus matched diabetics off GLP1-RAs, while also assessing the role of a 24-hour preprocedural liquid diet and bowel preparation in mitigating this risk.
From the journal's Aims & Scope
Research area (LetPub): Gastroenterology & Hepatology
Editor-in-chief Ronnie FassPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Helicobacter pylori-related gastroenterology studiesMedicine7.9%
- Gastroesophageal reflux and treatmentsMedicine6.6%
- Liver Disease Diagnosis and TreatmentMedicine6.4%
- Gastrointestinal motility and disordersMedicine5.4%
- Microscopic ColitisMedicine5.4%
- Gastrointestinal disorders and treatmentsMedicine5.3%
- Liver Disease and TransplantationMedicine5.3%
- Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Gastroenterology & Hepatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · GASTROENTEROLOGY & HEPATOLOGY · rank 77/153
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.32LetPub ·
- Impact factor (publisher) 2031
- 2.7Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 0.94LetPub ·
- SNIP 2026-06
- 0.94LetPub ·
- h-index
- 102LetPub ·
- h-index
- 165OpenAlex ·
- i10-index
- 5,534OpenAlex ·
- 2-year mean citedness
- 2.27OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 10.36%LetPub ·
Volume
- Articles per year
- 127LetPub ·
Articles by year OpenAlex count · 10,394 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 122 | 17 | 43 |
| 2025 | 188 | 19 | 277 |
| 2024 | 164 | 37 | 757 |
| 2023 | 139 | 27 | 882 |
| 2022 | 166 | 36 | 1,787 |
| 2021 | 173 | 35 | 2,203 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
118 daysMedian, submission to acceptance · P25–P75 75 days – 151 days
- Acceptance to online
- median 47 days (7 articles)
- Submission to online
- median 195 days
- Sample
- 22 articles with submission and acceptance dates (21 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1979
- ISSN
- 0192-0790
- Electronic ISSN
- 1539-2031
- Latest issue on the website
- Volume 60, Issue 9 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Clinical Gastroenterology
What CAS zone is Journal of Clinical Gastroenterology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical Gastroenterology is in Zone 3 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Clinical Gastroenterology?
The latest impact factor listed by LetPub is 2.32; CiteScore 5.4, h-index 165.
How long does peer review take at Journal of Clinical Gastroenterology?
Based on the dates recorded on 22 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 118 days (interquartile range 75–151 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Clinical Gastroenterology in?
The journal's website gives JCR Q3; by category, GASTROENTEROLOGY & HEPATOLOGY Q3 (77/153). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index Journal of Clinical Gastroenterology?
According to LetPub and DOAJ records, Journal of Clinical Gastroenterology is indexed in SCIE and Scopus.
Is Journal of Clinical Gastroenterology open access, and what is the APC?
Journal of Clinical Gastroenterology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .